Ph1/1b KQB198 in combo with patients with advanced hematologic malignancies
Clinical Trial
A Phase 1/1b Open-label Multicenter Dose Escalation and Dose Expansion Study Evaluating the Safety Tolerability Pharmacokinetics and Efficacy of KQB198 as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hematologic Malignancies (KQB198-102)